baclofen has been researched along with Hepatocellular Carcinoma in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " In this study, we investigated the antitumor effect of the GABABR agonist baclofen (Bac) on growth of human hepatocellular carcinoma (HCC) in vitro and in vivo." | 7.74 | Baclofen, a GABAB receptor agonist, inhibits human hepatocellular carcinoma cell growth in vitro and in vivo. ( Chen, F; Huang, W; Wang, T, 2008) |
| " In this study, we investigated the antitumor effect of the GABABR agonist baclofen (Bac) on growth of human hepatocellular carcinoma (HCC) in vitro and in vivo." | 3.74 | Baclofen, a GABAB receptor agonist, inhibits human hepatocellular carcinoma cell growth in vitro and in vivo. ( Chen, F; Huang, W; Wang, T, 2008) |
| "The treatment of alcohol dependence (AD) is a complex activity as the variables are numerous; however, those which must necessarily be taken into account are the type of AD, the internal comorbidities and the presence of any psychiatric comorbidity." | 1.43 | Liver Disease and Hepatocellular Carcinoma in Alcoholics: The Role of Anticraving Therapy. ( Borro, P; Leone, S; Testino, G, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borro, P | 1 |
| Leone, S | 1 |
| Testino, G | 1 |
| Lodewyks, C | 1 |
| Rodriguez, J | 1 |
| Yan, J | 1 |
| Lerner, B | 1 |
| Lipschitz, J | 1 |
| Nfon, C | 1 |
| Rempel, JD | 1 |
| Uhanova, J | 1 |
| Minuk, GY | 1 |
| Wang, T | 1 |
| Huang, W | 1 |
| Chen, F | 1 |
3 other studies available for baclofen and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Liver Disease and Hepatocellular Carcinoma in Alcoholics: The Role of Anticraving Therapy.
Topics: Acamprosate; Alcohol Deterrents; Alcoholics; Alcoholism; Baclofen; Carcinoma, Hepatocellular; Drug C | 2016 |
GABA-B receptor activation inhibits the in vitro migration of malignant hepatocytes.
Topics: Baclofen; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclic AMP | 2011 |
Baclofen, a GABAB receptor agonist, inhibits human hepatocellular carcinoma cell growth in vitro and in vivo.
Topics: Animals; Baclofen; Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cycl | 2008 |